APA (7th ed.) Citation

Ying He, Wangchun Lin, Zhongjie Cai, Yufan Huang, Maojin You, Meisheng Lei, & Ruijia Chen. (2023). Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Ying He, Wangchun Lin, Zhongjie Cai, Yufan Huang, Maojin You, Meisheng Lei, and Ruijia Chen. Cost-effectiveness Analysis of Transarterial Chemoembolization Combined with Lenvatinib as the First-line Treatment for Advanced Hepatocellular Carcinoma. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Ying He, et al. Cost-effectiveness Analysis of Transarterial Chemoembolization Combined with Lenvatinib as the First-line Treatment for Advanced Hepatocellular Carcinoma. Frontiers Media S.A., 2023.